Virology, Virus, Immunology, Immune system and Immunogenicity are his primary areas of study. His studies in Virology integrate themes in fields like Plasmid, Genetics, Antigen, Recombinant DNA and Molecular cloning. Ralf Wagner has included themes like Sequence motif, CRKL, Transfection and Adapter molecule crk in his Virus study.
His biological study deals with issues like Cytotoxic T cell, which deal with fields such as T cell and Priming. The Immune system study combines topics in areas such as Vaccinia, Adjuvant and Antibody. His work deals with themes such as Alanine transaminase and Lentivirus, which intersect with Immunogenicity.
His primary areas of investigation include Virology, Immunology, Immune system, Antigen and Immunogenicity. Ralf Wagner studies Virus which is a part of Virology. Ralf Wagner has researched Immune system in several fields, including Vaccinia and Viral vector.
His Antigen research incorporates elements of Molecular biology, HIV Antigens and DNA. His research on Molecular biology also deals with topics like
His main research concerns Virology, Antibody, Immune system, Immunogenicity and Antigen. His biological study spans a wide range of topics, including HIV vaccine and Gene, Recombinant DNA. His study in the field of Immunogen is also linked to topics like Severe acute respiratory syndrome coronavirus 2 and Coronavirus antibody.
His work on Neutralizing antibody, T cell and Immunization as part of general Immune system research is often related to Conjugate, thus linking different fields of science. Ralf Wagner interconnects Heterologous, DNA vaccination and B cell in the investigation of issues within Immunogenicity. His study in Antigen is interdisciplinary in nature, drawing from both Neutralization and Replication.
His primary areas of investigation include Antibody, Virology, Immunogenicity, Immune system and Antigen. His work on Antigenicity as part of general Antibody research is frequently linked to Conjugate, bridging the gap between disciplines. Ralf Wagner works in the field of Virology, namely Vaccination.
Ralf Wagner combines subjects such as HIV vaccine and DNA vaccination with his study of Immunogenicity. His research in the fields of Neutralizing antibody and Antigen-presenting cell overlaps with other disciplines such as Covalent bond and Conjugated system. In his research, Seroprevalence, Serology and Seroconversion is intimately related to Neutralization, which falls under the overarching field of Antigen.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant
Sucheep Piyasirisilp;Francine E. McCutchan;Jean K. Carr;Eric Sanders-Buell.
Journal of Virology (2000)
Characterization of a Virtually Full-Length Human Immunodeficiency Virus Type 1 Genome of a Prevalent Intersubtype (C/B′) Recombinant Strain in China
Ling Su;Marcus Graf;Yuanzhi Zhang;Hagen von Briesen.
Journal of Virology (2000)
Multiple Effects of Codon Usage Optimization on Expression and Immunogenicity of DNA Candidate Vaccines Encoding the Human Immunodeficiency Virus Type 1 Gag Protein
Ludwig Deml;Alexandra Bojak;Stephanie Steck;Marcus Graf.
Journal of Virology (2001)
Virus-like particles-universal molecular toolboxes.
Christine Ludwig;Ralf Wagner.
Current Opinion in Biotechnology (2007)
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.
Alexandre Harari;Pierre-Alexandre Bart;Wolfgang Stöhr;Gonzalo Tapia.
Journal of Experimental Medicine (2008)
Multiparameter RNA and codon optimization: a standardized tool to assess and enhance autologous mammalian gene expression.
Stephan Fath;Asli Petra Bauer;Michael Liss;Anne Spriestersbach.
PLOS ONE (2011)
Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus : Implications for the safety of lentiviral vectors
Ralf Wagner;Marcus Graf;Kurt Bieler;Hans Wolf.
Human Gene Therapy (2000)
The GeneOptimizer Algorithm: using a sliding window approach to cope with the vast sequence space in multiparameter DNA sequence optimization
David Raab;Marcus Graf;Frank Notka;Thomas Schödl.
Systems and Synthetic Biology (2010)
Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo.
Frank Notka;Georg Meier;Ralf Wagner.
Antiviral Research (2004)
Expanding the Genetic Code of Lactococcus lactis and Escherichia coli to Incorporate Non-canonical Amino Acids for Production of Modified Lantibiotics.
Maike Bartholomae;Tobias Baumann;Jessica H Nickling;David Peterhoff.
Frontiers in Microbiology (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Amsterdam
University of Lausanne
University of Cambridge
Spanish National Research Council
Duke University
Duke University
Arizona State University
Duke University
University of Erlangen-Nuremberg
University of Ulm
Imperial College London
Sciences Po
University of California, Davis
University of Aberdeen
Jiangnan University
Sapienza University of Rome
University of Veterinary and Pharmaceutical Sciences
University of Kentucky
Swiss Federal Institute for Forest, Snow and Landscape Research
University of Massachusetts Lowell
Stockholm Resilience Centre
University of Basel
University of Cambridge
Cardiovascular Institute of the South
University of Nottingham
University of Lorraine